Immunology Archives - Page 2 of 2 - El·lipse

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.

22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

Patients who received redemsivir had a 31% faster recovery time than those who received placebo. There was a 4-day reduction in hospital stay. | Picture by Francisco Avia.

08.05.2020

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

60-90% of the adult world population is infected by cytomegalovirus. It is a latent and asymptomatic infection. | Picture by Qimono from Pixabay.

27.02.2020

New protection biomarker against cytomegalovirus in kidney transplant patients

Researchers find that NFAT5 helps control the levels of interferons during the immune response. Image by allinonemovie from Pixabay.

12.02.2020

New key element to control interferons during the immune response

10.02.2020

“Being able to see the sea everyday from work is wonderful”

The IMIM organised a course on the latest advances on Immunotherapy. | Picture by Daniel Frank from Unsplash.

29.11.2019

Moving forward in immunotherapy research

The sleep-awake cycle is the classic example of circadian rhythm, but not the only one. Photo by Levi Guzman in Unsplash.

27.11.2019

Dancing to the circadian rhythms

A mathematical prediction of the spatial trajectory of T lymphocytes during an HIV infection, according to a recent study.

15.07.2019

T lymphocyte trajectories in HIV-infected lymph nodes

Human microbial ecosystem, artistic representation.

28.02.2019

The microbiome club and the immune system

White blood cell, Creative Commons CC0

22.11.2018

What is immunotherapy?

The Spanish microbiologist, and CRISPR discoverer, Francisco J.M. Mojica, received the Jaime I Award for Basic Research, due to his discovery.

30.07.2016

Francisco Mojica: “I’m incredibly proud of having been part of the CRISPR revolution”